S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7125 +0.22%
PRE-MKT · 07:20 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
CB
INSIDER · ATRA · Atara Biotherapeutics, Inc. · DIRECTOR

Cherry Brian N

Every open-market transaction filed under this name, Sep 4 to Sep 4.

Filings
1
1 buy · 0 sells
Bought
$1M
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 4ATRAAtara Biotherapeutics, Inc.DirectorBuy104,166$9.60$1M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.